Literature DB >> 21880794

Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.

Ambika P Ashraf1, Timothy Beukelman, Valerie Pruneta-Deloche, David R Kelly, Abhimanyu Garg.   

Abstract

CONTEXT: Type 1 hyperlipoproteinemia (T1HLP) in childhood is most often due to genetic deficiency of lipoprotein lipase (LPL) or other related proteins.
OBJECTIVE: The aim was to report a case of marked hypertriglyceridemia and recurrent acute pancreatitis due to the presence of LPL autoantibody in a young girl who was subsequently diagnosed with Sjögren's syndrome. SUBJECT AND METHODS: A 9-yr-old African-American girl presented with acute pancreatitis and serum triglycerides of 4784 mg/dl. Strict restriction of dietary fat reduced serum triglycerides, but she continued to experience recurrent pancreatitis. Approximately 18 months thereafter, she developed transient pauciarticular arthritis with elevated serum antinuclear antibody (>1:1280). Minor salivary gland biopsy revealed chronic sialadenitis with a dense periductal lymphocytic aggregate suggestive of Sjögren's syndrome. Genomic DNA was analyzed for LPL, GPIHBP1, APOA5, APOC2, and LMF1. Immunoblotting was performed to detect serum LPL autoantibody.
RESULTS: The patient had no disease-causing variants in LPL, GPIHBP1, APOA5, APOC2, or LMF1. Immunoblotting revealed serum LPL antibody. The patient responded to immunosuppressive therapy for Sjögren's syndrome with resolution of hypertriglyceridemia.
CONCLUSIONS: Unexplained T1HLP in childhood could be secondary to LPL deficiency induced by autoantibodies. Therefore, diagnosis of autoimmune T1HLP should be entertained if clinical features are suggestive of an autoimmune process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880794      PMCID: PMC3205898          DOI: 10.1210/jc.2011-1113

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Gene environment interaction and plasma triglyceride levels: the crucial role of lipoprotein lipase.

Authors:  M R Hayden; M S Liu; Y Ma
Journal:  Clin Genet       Date:  1994-07       Impact factor: 4.438

2.  Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.

Authors:  Christophe Marçais; Bruno Verges; Sybil Charrière; Valérie Pruneta; Micheline Merlin; Stéphane Billon; Laurence Perrot; Jocelyne Drai; Agnès Sassolas; Len A Pennacchio; Jamila Fruchart-Najib; Jean-Charles Fruchart; Vincent Durlach; Philippe Moulin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Autoimmune hyperchylomicronemia.

Authors:  S Kihara; Y Matsuzawa; M Kubo; S Nozaki; T Funahashi; S Yamashita; N Sho; S Tarui
Journal:  N Engl J Med       Date:  1989-05-11       Impact factor: 91.245

4.  Rare case of autoimmune hyperchylomicronemia during pregnancy.

Authors:  T Yoshimura; M Ito; Y Sakoda; S Kobori; H Okamura
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1998-01       Impact factor: 2.435

5.  Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.

Authors:  A L García-Otín; F Civeira; J Peinado-Onsurbe; C Gonzalvo; M Llobera; M Pocoví
Journal:  Eur J Endocrinol       Date:  1999-11       Impact factor: 6.664

6.  Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.

Authors:  Valérie Pruneta-Deloche; Christophe Marçais; Laurence Perrot; Agnès Sassolas; Mireille Delay; Bruno Estour; Michel Lagarde; Philippe Moulin
Journal:  J Clin Endocrinol Metab       Date:  2005-04-19       Impact factor: 5.958

7.  Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy.

Authors:  V Pruneta; P Moulin; F Labrousse; P J Bondon; G Ponsin; F Berthezene
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

8.  Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?

Authors:  Jozélio Freire de Carvalho; Eduardo Ferreira Borba; Vilma Santos Trindade Viana; Cleonice Bueno; Elaine Pires Leon; Eloísa Bonfá
Journal:  Arthritis Rheum       Date:  2004-11

9.  Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia.

Authors:  Myriam Moret; Valérie Pruneta-Deloche; Agnès Sassolas; Christophe Marcais; Philippe Moulin
Journal:  Atherosclerosis       Date:  2009-07-28       Impact factor: 5.162

10.  Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor.

Authors:  H Nagasaka; H Kikuta; H Chiba; T Murano; H Harashima; A Ohtake; H Senzaki; N Sasaki; I Inoue; S Katayama; K Shirai; K Kobayashi
Journal:  Eur J Pediatr       Date:  2003-01-23       Impact factor: 3.183

View more
  5 in total

1.  Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.

Authors:  Anne P Beigneux; Kazuya Miyashita; Michael Ploug; Dirk J Blom; Masumi Ai; MacRae F Linton; Weerapan Khovidhunkit; Robert Dufour; Abhimanyu Garg; Maureen A McMahon; Clive R Pullinger; Norma P Sandoval; Xuchen Hu; Christopher M Allan; Mikael Larsson; Tetsuo Machida; Masami Murakami; Karen Reue; Peter Tontonoz; Ira J Goldberg; Philippe Moulin; Sybil Charrière; Loren G Fong; Katsuyuki Nakajima; Stephen G Young
Journal:  N Engl J Med       Date:  2017-04-05       Impact factor: 91.245

Review 2.  Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights.

Authors:  Ricardo Stein; Filipe Ferrari; Fernando Scolari
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

3.  GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Authors:  Xuchen Hu; Geesje M Dallinga-Thie; G Kees Hovingh; Sandy Y Chang; Norma P Sandoval; Tiffany Ly P Dang; Isamu Fukamachi; Kazuya Miyashita; Katsuyuki Nakajima; Masami Murakami; Loren G Fong; Michael Ploug; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

Review 4.  Chylomicronemia from GPIHBP1 autoantibodies.

Authors:  Kazuya Miyashita; Jens Lutz; Lisa C Hudgins; Dana Toib; Ambika P Ashraf; Wenxin Song; Masami Murakami; Katsuyuki Nakajima; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2020-09-18       Impact factor: 5.922

5.  Case Studies in Pediatric Lipid Disorders and Their Management.

Authors:  Ambika P Ashraf; Bhuvana Sunil; Vaneeta Bamba; Emily Breidbart; Preneet Cheema Brar; Stephanie Chung; Anshu Gupta; Aditi Khokhar; Seema Kumar; Marissa Lightbourne; Manmohan K Kamboj; Ryan S Miller; Nivedita Patni; Vandana Raman; Amy S Shah; Don P Wilson; Brenda Kohn
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.